Brief: Acadia Pharmaceuticals Q2 EPS USD 0.18
04/08/2026 21:06
BRIEF-Acadia Pharmaceuticals Q2 EPS USD 0.18 Aug 04 (Reuters) - Acadia Pharmaceuticals Q2 pretax profit USD 46.473 million.
- Q2 net income USD 31.5 million
- Q2 product sales USD 307.959 million
- Q2 operating expenses USD 270.123 million
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry